Ngar Yee Louie is Director at MAIA Biotechnology, Inc. (MAIA). They have made 5 open-market trades across 1 company since 2022, most recently 2025-12-22.
CIK 0001913264
5 open-market purchases totalling $847K since 2022, never a sale. Across 5 scored buys the stock is up 22.6% at ninety days, and 20.7 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| MAIA | 1,248,888 | $1.4M |
Shares reported on the most recent Form 4, priced at the 2025-12-23 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 60% | 60% |
| Avg Move | +11.1% | +19.6% | +22.6% |
| Alpha | +9.7% | +19.6% | +20.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MAIA | BUY | 2025-12-22 | 2025-12-23 | $1.22 | $199K | +8.5% | +70.2% | +5.0% |
| MAIA | BUY | 2024-04-25 | 2024-04-26 | $2.03 | $40K | -1.0% | +33.9% | +10.7% |
| MAIA | BUY | 2024-03-14 | 2024-03-15 | $1.17 | $400K | +63.2% | +34.2% | +149.3% |
| MAIA | BUY | 2023-04-27 | 2023-04-28 | $2.25 | $108K | +2.3% | -9.4% | -12.8% |
| MAIA | BUY | 2022-08-01 | 2022-08-02 | $5.00 | $100K | -17.3% | -31.1% | -39.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.